Search Within

Viktoriya Paroder

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (10)
  3. Review (1)
Groups
  1. Body Imaging Service (29)
  2. Department of Medicine (29)
  3. Radiology, Department of (29)
  4. Solid Tumor Oncology Division (29)
  5. Gastrointestinal Oncology Service (25)
  6. Hematologic Malignancies, Division of (17)

More Groups

People
  1. Yelena Janjigian (11)
  2. Geoffrey Ku (10)
  3. Marinela Capanu (10)
  4. Joanne Chou (9)
  5. Steven Maron (9)
  6. Jinru Shia (7)

More People

Years
  1. 2024 (3)
  2. 2023 (5)
  3. 2022 (8)
  4. 2021 (5)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Journal of Gastrointestinal Oncology (5)
  3. American Journal of Roentgenology (2)
  4. Annals of Oncology (2)
  5. Journal of Nuclear Medicine (2)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Pioneer Bioscience Publishing Company (5)
  3. American Association for Cancer Research (2)
  4. American Roentgen Ray Society (2)
  5. Oxford University Press (2)
  6. Society of Nuclear Medicine (2)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Natural language processing of computed tomography reports to label metastatic phenotypes with prognostic significance in patients with colorectal cancer
    Journal Article

    Causa Andrieu, P.; Golia Pernicka, J. S.; Yaeger, R.; Lupton, K.; Batch, K.; Zulkernine, F.; Simpson, A. L.; Taya, M.; Gazit, L.; Nguyen, H.; more...
    JCO Clinical Cancer Informatics (2022)

    Fulltext@MSK | Save
  • Feasibility, safety, and biodistribution of 18F-BMS-986229 PET in patients with esophagogastric (EG) cancer
    Meeting Abstract

    Cytryn, S.; Lumish, M.; Paroder, V.; Philemond, S.; Lewis, J.; Lyashchenko, S.; Janjigian, Y.; Pandit-Taskar, N.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
    Journal Article

    Su, W.; Mukherjee, R.; Yaeger, R.; Son, J.; Xu, J.; Na, N.; Timaul, N. M.; Hechtman, J.; Paroder, V.; Lin, M.; more...
    Molecular Cell (2022)

    Fulltext@MSK | Save
  • Can (18)F-FDG PET/CT radiomics features predict clinical outcomes in patients with locally advanced esophageal squamous cell carcinoma?
    Journal Article

    Jayaprakasam, V. S.; Gibbs, P.; Gangai, N.; Bajwa, R.; Sosa, R. E.; Yeh, R.; Greally, M.; Ku, G. Y.; Gollub, M. J.; Paroder, V.
    Cancers (2022)

    Fulltext@MSK | Save
  • MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer
    Journal Article

    Jayaprakasam, V. S.; Paroder, V.; Gibbs, P.; Bajwa, R.; Gangai, N.; Sosa, R. E.; Petkovska, I.; Golia Pernicka, J. S.; Fuqua, J. L. 3rd; Bates, D. D. B.; more...
    European Radiology (2022)

    Fulltext@MSK | Save
  • Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: A case report
    Journal Article

    de Castria, T. B.; Tang, L.; Moro Queiroz, M.; Mendes Awni, B.; Paroder, V.; Shamseddine, A.; Mendonca Bariani, G.; Mukherji, D.; Matar, C. F.; dos Santos Fernandes, G.; more...
    Journal of Gastrointestinal Oncology (2021)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Imaging HER2-positive metastatic esophagogastric cancer with (89)Zr-trastuzumab PET and (18)F-FDG PET
    Meeting Abstract

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Janjigian, Y. Y.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save